Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.
Ontology highlight
ABSTRACT: The hedgehog pathway, for which sonic hedgehog (Shh) is the most prominent ligand, is highly conserved and is tightly associated with embryonic development in a number of species. This pathway is also tightly associated with the development of several types of cancer, including basal cell carcinoma (BCC) and acute promyelocytic leukemia, among many others. Inactivating mutations in Patched-1 (PTCH1), leading to ligand-independent pathway activation, are frequent in several cancer types, but most prominent in BCC. This has led to the development of several compounds targeting this pathway as a cancer therapeutic. These compounds target the inducers of this pathway in Smoothened (SMO) and the GLI transcription factors, although targeting SMO has had the most success. Despite the many attempt
SUBMITTER: Carpenter RL
PROVIDER: S-EPMC6434684 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA